CClinicalTrials.gg
Not yet recruitingNCT07389850ReproEVOUpdated Feb 5, 2026

Evaluation of the Evolution of Proprioceptive Reweighting Abilities Following Anterior Cruciate Ligament Reconstruction Surgery

An interventional study of ReproEVO intervention in Anterior Cruciate Ligament Rupture With Ligamentoplasty, sponsored by University Hospital, Brest. Not yet recruiting at 3 sites in France. Open to participants aged 15 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-02-05.

Sponsored by University Hospital, Brest · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Not applicable
Ages
15 Years to 40 Years
Sex
All
01

Study summary

Anterior cruciate ligament (ACL) injury is the most common knee injury among athletes who play contact sports involving pivoting. ACL reconstruction (ACLR) combined with rehabilitation is the standard treatment for ACL tears in athletes, and rehabilitation is one of the keys to success. The overall return to sport rate is 80%, but the return to pre-injury level of sport is only 65% and the return to the same level of competition is only 55%. The recurrence rate is close to 20%.

During rehabilitation and sports practice, proprioceptive information is essential for adjusting the muscle sensorimotor loop and enabling optimal movement.

Athletes can thus be classified as plastic or rigid . Our hypothesis is to show that the proportion of "plastic" patients 9 months post-operative following ACL reconstruction is higher than that found in the same population 3 months post-operative, thus demonstrating the progression of proprioceptive integration abilities after ACL reconstruction surgery.

Read the detailed description

Anterior cruciate ligament (ACL) injury is the most common knee injury among athletes who play contact sports involving pivoting. ACL reconstruction (ACLR) combined with rehabilitation is the standard treatment for ACL tears in athletes, and rehabilitation is one of the keys to success. The overall return to sport rate is 80%, but the return to pre-injury level of sport is only 65% and the return to the same level of competition is only 55%. The recurrence rate is close to 20%. Although the number of studies on the subject is growing, there is currently no consensus on rehabilitation protocols.

During rehabilitation and sports practice, proprioceptive information is essential for adjusting the muscle sensorimotor loop and enabling optimal movement.

We have demonstrated that athletes and athletes after ACL reconstruction show variability in the integration of proprioceptive information during a complex balance task.

Athletes can thus be classified as plastic (able to vary the source of proprioceptive information depending on conditions) or rigid (unable to do so).

Our hypothesis is to show that the proportion of "plastic" patients 9 months post-operative following ACL reconstruction is higher than that found in the same population 3 months post-operative, thus demonstrating the progression of proprioceptive integration abilities after ACL reconstruction surgery.

02

Conditions studied

  • Anterior Cruciate Ligament Rupture With Ligamentoplasty

Keywords

  • Anterior Cruciate Ligament
  • Anterior Cruciate Ligament Reconstruction
  • Central Nervous System
  • Proprioceptive reweighting
  • Pivot-contact sport
  • Plastic patient
  • Athletes
03

In context

Lead sponsor

University Hospital, Brest is the lead sponsor of 594 studies on the registry; 135 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged between 15 and 40;
  • Patients with ACL rupture scheduled for ACL reconstruction surgery;
  • Patients able to maintain a stable bipedal standing position without technical assistance and with their eyes closed;
  • Consent of the patient, parents, legal guardians, or guardians to the recording (for minor patients) of data for research and publication purposes.

Exclusion criteria

Exclusion Criteria:

  • Recent osteoarticular pathology (i.e., less than three months) of the lower limbs, whether traumatic or not, other than ACL rupture;
  • Proven disabling neurological pathology;
  • Pain in the musculoskeletal system during exercise (excluding the operated knee);
  • Fatigue assessed using the Borg scale > 6;
  • Skin allergy to an adhesive product.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    Patients with Anterior Cruciate Ligament

    Patients with Anterior Cruciate Ligament (ACL) rupture scheduled for ACL reconstruction surgery

    Procedure: ReproEVO intervention

Interventions

  • ProcedureReproEVO intervention

    After the inclusion visit, each assessment will include an examination of standing balance in two support conditions: hard floor or soft floor and two conditions of vibration of the Achilles tendons or lumbar muscles, performed randomly over five trials for each condition. The subjects stand with their eyes covered by an opaque mask. Vibrators are positioned at both locations and vibrated randomly after a trial without recording to perceive the destabilizing effect induced by the vibration. The data is recorded using a force platform on the floor. Subjects will be seated and strapped into a rigid device attached to their leg. The device is connected to a motor that maintains a constant speed. Maximum strength will be measured at two different speeds. Finally, at each assessment, the subjects will complete questionnaires about their fear of pain, their assessment of their knee's capabilities, and the activities they engage in.

06

What researchers measure

Primary outcomes

  1. Assessment of progress in proprioceptive reweighting after knee ligament reconstruction

    Difference between the mean proprioceptive reweighting coefficient (RPw) preoperatively and 3 months postoperatively

    Time frame: Baseline, 3 months after surgery and 9 months after surgery

Secondary outcomes

  1. Assesment of the variation in weighting between before and after the operation

    Difference between the mean proprioceptive reweighting coefficient (RPw) preoperatively and 3 months postoperatively

    Time frame: Baseline and 3 months postoperatively

  2. Assess postural control

    Difference in the size of the shift in the center of pressure in a static standing position, with eyes open and closed

    Time frame: Baseline, at 3 months postoperatively and at 9 months postoperatively

  3. Assess your Anterior Cruciate Ligament - Return to Sport and Injury (ACL-RSI) perception score

    Assess your Anterior Cruciate Ligament - Return to Sport and Injury (ACL-RSI) perception score (0 : Not at all sure; 10: Completely safe) at the inclusion visit (preoperative); at 3 months postoperatively and at 9 months postoperatively

    Time frame: Baseline, at 3 months postoperatively and at 9 months postoperatively

  4. Assess the subjective IKDC activity score

    Assess the subjective IKDC activity score (0: Never; 10: Always) at the inclusion visit (preoperative); at 3 months postoperatively and at 9 months postoperatively.

    Time frame: Baseline, at 3 months postoperatively and at 9 months postoperatively

07

Study locations

3 sites
  • Brest University Hospital
    Brest, 29609, France
  • Montpellier University Hospital
    Montpellier, 34000, France
    • Benoît ATTALIN, Doctor · Contact · benoit.attalin@gmail.com · +33687643336
    • Benoît ATTALIN, Doctor · Principal investigator
  • Dr. STER Clinic, Saint Clément de Rivière
    Saint-Clément-de-Rivière, 34980, France
08

References and documents

Individual participant data

Plan to share: Yes — All collected data that underlie results in a publication

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07389850
Lead sponsor
University Hospital, Brest
Responsible party
Sponsor
First posted
Feb 5, 2026
Start date
Feb 20, 2026 (estimated)
Primary completion
May 20, 2028 (estimated)
Completion
May 20, 2028 (estimated)
Last update
Feb 5, 2026

Study contacts

Olivier REMY-NERIS, Professor
Contact
olivier.remyneris@chu-brest.fr
+33298223152

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion